Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?

Local consolidative therapy in oligometastatic non-small-cell lung cancer after effective systemic treatment: who will benefit?

Saved in:

Bibliographic Details
Main Authors:	Jiayi Deng, Mingyi Yang, Qing Zhou
Format:	Article
Language:	English
Published:	China Anti-Cancer Association 2025-01-01
Series:	Cancer Biology & Medicine
Online Access:	https://www.cancerbiomed.org/content/22/1/21
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Factors Affecting the Survival of Patients with Oligometastatic Non-Small-Cell Lung Cancer: A Meta-Analysis
by: Yu Shi, et al.
Published: (2019-01-01)

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer
by: Daniel R. Gomez, et al.
Published: (2012-01-01)

Anlotinib as Maintenance Therapy After First-Line Chemotherapy Combined with Consolidation Radiation for Extensive-Stage Small Cell Lung Cancer
by: Jinbo Ma MD, et al.
Published: (2025-01-01)

Brief report: impact of consolidation durvalumab on unresectable non-small cell lung cancer with driver mutations
by: Jason C.S. Ho, et al.
Published: (2024-01-01)

Impact of Immune Checkpoint Inhibitors and Local Radical Treatment on Survival Outcomes in Synchronous Oligometastatic NSCLC
by: Mandy Jongbloed, MD, et al.
Published: (2025-03-01)

Treatment of oligometastatic breast cancer: The role of patient selection
by: Riccardo Ray Colciago, et al.
Published: (2025-02-01)

Clinical efficacy of cytoreductive radical prostatectomy in the treatment of oligometastatic hormone-sensitive prostate cancer
by: Feng Qi, et al.
Published: (2025-01-01)

Characterization of the genomic landscape in liver oligometastatic NSCLC
by: Rongxin Liao, et al.
Published: (2025-01-01)

The effect of the relative dose intensity of chemoradiotherapy on the effectiveness of therapy of locally advanced unresectable non-small cell lung cancer
by: A. E. Glukhareva, et al.
Published: (2024-03-01)

Optimizing the Benefits of Mental Practice on Motor Acquisition and Consolidation with Moderate-Intensity Exercise
by: Rannaud Monany, Dylan, et al.
Published: (2023-07-01)

Patients outcomes in lung adenocarcinoma transforming to small-cell lung cancer after tyrosine kinase inhibitor therapy
by: Shuai Wang, et al.
Published: (2025-02-01)

Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
by: Michael Ghadimi, et al.
Published: (2025-02-01)

Development and Validation of an MRI‐Based Radiomics Nomogram to Predict the Prognosis of De Novo Oligometastatic Prostate Cancer Patients
by: Wen‐Qi Liu, et al.
Published: (2024-12-01)

Risk factors for non-benefit of implantable cardioverter defibrillator therapy
by: Fabienne Kreimer, et al.
Published: (2025-01-01)

Whole lung radiomic features are associated with overall survival in patients with locally advanced non-small cell lung cancer treated with definitive radiotherapy
by: Meng Yan, et al.
Published: (2025-01-01)

AMPK: An energy sensor for non-small cell lung cancer progression and treatment
by: Zhi-Ting Zhong, et al.
Published: (2025-02-01)

Non–Small-Cell Lung Cancer. Unusual Small Bowel Metastasis with Invagination
by: Miguel Ángel Serra Valdés, et al.
Published: (2017-07-01)

Pancreatic Cancer: Who Benefits from Curative Resection?
by: HG Beger, et al.
Published: (2002-01-01)

Non-small cell lung cancer and the tumor microenvironment: making headway from targeted therapies to advanced immunotherapy
by: Anna De Lucia, et al.
Published: (2025-02-01)

Advances in adjuvant therapy for operable N2 non-small cell lung cancer: a narrative review
by: Lei Liu, et al.
Published: (2025-01-01)

Real-world outcomes of prophylactic cranial irradiation utilization and efficacy for patients with extensive-stage small cell lung cancer treated with consolidative thoracic radiotherapy
by: Abdul H. Lone, et al.
Published: (2025-03-01)

Metastatic Ureteral Involvement of Non-Small Cell Lung Cancer
by: Koichi Kodama, et al.
Published: (2011-01-01)

Genetic and Biochemical Alterations in Non-Small Cell Lung Cancer
by: Jackie L. Johnson, et al.
Published: (2012-01-01)

Development and validation of a predictive model for lymph node metastases in peripheral non-small cell lung cancer with a tumor diameter ≤ 2.0 cm and a consolidation-to-tumor ratio > 0.5
by: Dongyu Li, et al.
Published: (2025-01-01)

Effects of removing reimbursement restrictions on targeted therapy accessibility for non-small cell lung cancer treatment in Taiwan: an interrupted time series study
by: Jason C Hsu, et al.
Published: (2019-03-01)

Deregulated methylation and expression of PCDHGB7 in patients with non-small cell lung cancer: a novel prognostic and immunological biomarker
by: Yue Yuan, et al.
Published: (2025-01-01)

Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120)
by: Mauro Zukin, et al.
Published: (2025-01-01)

Low-exhaustion peripheral circulating γδ T cells serve as a biomarker for predicting the clinical benefit rate of non-small cell lung cancer (NSCLC) patients to chemotherapy or targeted therapy: a single-center retrospective study
by: Dongdong Zhang, et al.
Published: (2025-01-01)

A Case of Non-Small Cell Lung Cancer with Possible “Disease Flare” on Nivolumab Treatment
by: Shotaro Chubachi, et al.
Published: (2016-01-01)

The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
by: Guomin Gu, et al.
Published: (2024-12-01)

Bilateral Choroidal Metastasis from Non-Small Cell Lung Cancer
by: Tariq Namad, et al.
Published: (2014-01-01)

Optimising primary molecular profiling in non-small cell lung cancer.
by: R D Schouten, et al.
Published: (2024-01-01)

Comparison of the Efficacy and Safety of PD‐1/PD‐L1 Inhibitors in the Treatment of Small Cell Lung Cancer
by: Qichen Zhang, et al.
Published: (2025-01-01)

Risk factors for mediastinal lymph node metastasis and lung metastasis in papillary thyroid carcinoma patients: who benefits from preoperative computed tomography?
by: Yoko Omi, et al.
Published: (2024-04-01)

Efficacy and Safety of Anlotinib and PD-1/L1 Inhibitors as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer Patients who Have Achieved Stable-Disease After First-Line Treatment with Chemotherapy and Immunotherapy: A Retrospective Study
by: Yi Peng MD, et al.
Published: (2025-01-01)

Machine learning predicted fast progression after initiation of immune checkpoint inhibitors in advanced non-small cell lung cancer
by: Martin Stockler, et al.
Published: (2024-07-01)

Efficacy of first-line chemotherapy combined with immunotherapy or anti-angiogenic therapy in advanced KRAS-mutant non-small cell lung cancer
by: Huiping Qiang, et al.
Published: (2025-03-01)

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy
by: Michael Thomas, et al.
Published: (2025-01-01)

Evaluation of treatment strategies for patients with stage IIIA non-small cell lung cancer in the immunotherapy era
by: Amy Alabaster, et al.
Published: (2024-01-01)

Operative versus Nonoperative Treatment in Patients with Advanced Non-Small-Cell Lung Cancer: Recommended for Surgery
by: Hui Wang, et al.
Published: (2023-01-01)